Video
Become a Member to Save

VEYVONDI®▼(vonicog alfa) On-Demand Real-World Experience With Dr. Carolyn Millar

In the recording, Dr. Carolyn Millar starts by discussing some of the challenges in von Willebrand disease treatment. She then describes the case of a 35-year-old male with type 2A VWD who currently presents with prolonged epistaxis. Dr. Millar goes on to discuss the basics of desmopressin use and the specific use in this case. Finally, she lists potential cases which may require the use of VWF replacement therapy and explains how VEYVONDI was used in this on-demand case, including guidance on dosing for other on-demand uses of Veyvondi.

Von Willebrand Disease
Allied Professional
CMT
FY1/FY2
General Practitioner
Nurse
Specialist Nurse
ST3+
Bleeding Disorders
Contribute

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard

Adverse events should also be reported to Takeda UK Ltd. at: AE.GBR-IRL@takeda.com

Rare Disease Hub is for UK healthcare professionals only. This website has been initiated and developed by Takeda.

Copyright © 2023 Takeda UK Ltd.

 

C-APROM/GB/HG/0153

July 2023